Pacira Biosciences, Stock Price on November 12, 2024
| PCRX Stock | USD 16.91 0.27 1.62% |
Below is the normalized historical share price chart for Pacira BioSciences, extending back to February 03, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pacira BioSciences, stands at 16.91, as last reported on the 29th of November, with the highest price reaching 17.01 and the lowest price hitting 16.47 during the day.
If you're considering investing in Pacira Stock, it is important to understand the factors that can impact its price. At this stage we consider Pacira Stock to be very steady. Pacira BioSciences, maintains Sharpe Ratio (i.e., Efficiency) of 0.0729, which implies the firm had a 0.0729% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Pacira BioSciences,, which you can use to evaluate the volatility of the company. Please check Pacira BioSciences,'s Semi Deviation of 2.13, coefficient of variation of 1004.43, and Risk Adjusted Performance of 0.0831 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.
At this time, Pacira BioSciences,'s Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.7 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 32.8 K in 2024. . At this time, Pacira BioSciences,'s Price Earnings Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 11.74 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024. Pacira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2011 | 200 Day MA 22.5501 | 50 Day MA 16.3728 | Beta 0.818 |
Pacira |
Sharpe Ratio = 0.0729
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PCRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.38 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Pacira BioSciences, is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pacira BioSciences, by adding it to a well-diversified portfolio.
Price Book 1.025 | Enterprise Value Ebitda 28.6909 | Price Sales 1.1056 | Shares Float 45.7 M | Wall Street Target Price 18 |
Related Headline
Phibro Animal Headline on 12th of November 2024
Phibro is at a 52-week high, but can investors hope for more gains in the future We take a look at the companys fundamentals for clues.
Pacira BioSciences, Valuation on November 12, 2024
It is possible to determine the worth of Pacira BioSciences, on a given historical date. On November 12, 2024 Pacira was worth 17.13 at the beginning of the trading date compared to the closed value of 16.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pacira BioSciences, stock. Still, in general, we apply an absolute valuation method to find Pacira BioSciences,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pacira BioSciences, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pacira BioSciences,'s related companies.
| Open | High | Low | Close | Volume | |
| 17.43 | 17.87 | 17.35 | 17.50 | 536,041 | |
11/12/2024 | 17.13 | 17.54 | 16.40 | 16.80 | 732,373 |
| 16.81 | 17.02 | 16.11 | 16.45 | 650,500 |
| Backtest Pacira BioSciences, | | | Pacira BioSciences, History | | | Pacira BioSciences, Valuation | Previous | Next |
Pacira BioSciences, Trading Date Momentum on November 12, 2024
| On November 13 2024 Pacira BioSciences, was traded for 16.45 at the closing time. The top price for the day was 17.02 and the lowest listed price was 16.11 . The trading volume for the day was 650.5 K. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.08% . The trading delta at closing time against the current closing price is 3.63% . |
Pacira BioSciences, Fundamentals Correlations and Trends
By evaluating Pacira BioSciences,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pacira financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pacira BioSciences, Stock history
Pacira BioSciences, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pacira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pacira BioSciences, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pacira BioSciences, stock prices may prove useful in developing a viable investing in Pacira BioSciences,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 52 M | 35.9 M | |
| Net Income Applicable To Common Shares | 18.3 M | 19.2 M |
Pacira BioSciences, Quarterly Net Working Capital |
|
Pacira BioSciences, Stock Technical Analysis
Pacira BioSciences, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pacira BioSciences, Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Pacira BioSciences, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pacira BioSciences, November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Pacira BioSciences, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacira BioSciences, shares will generate the highest return on investment. By undertsting and applying Pacira BioSciences, stock market strength indicators, traders can identify Pacira BioSciences, entry and exit signals to maximize returns
Pacira BioSciences, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pacira BioSciences,'s price direction in advance. Along with the technical and fundamental analysis of Pacira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pacira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0831 | |||
| Jensen Alpha | 0.1036 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0497 | |||
| Treynor Ratio | 0.2105 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.